Affiliation:
1. The Ohio State University Wexner Medical Center
2. The Ohio State University
Abstract
Abstract
Background:
The response rates to immune checkpoint inhibitors (ICI) remain low (13-20%) in metastatic head and neck cancer patients and better understanding of factors predictive of response to these agents is urgently needed. Here we explore the impact of smoking status, marijuana use and alcohol on treatment outcomes in recurrent-metastatic (R/M) head and neck squamous cell carcinoma (HNSCC) treated with ICI.
Methods:
We performed a retrospective analysis of 201 R/M HNSCC patients treated with ICI between January 15th 2016 and April 9th 2020 at a single institution.
Results:
Gender: 154 male (77%), 47 female (23%). Median age 61 (IQR: 55-68). ICI drug: pembrolizumab 100 (50%), nivolumab 91 (45%), nivolumab+ipilimumab 10 (5%). Line of therapy: first: 98 (49%), second and beyond: 103 (51%). Tumor site: oropharynx 84 (42%), oral cavity 45 (22%), larynx 26 (13%), other sites 46 (23%). p16 tumor status: negative 132 (66%), positive 69 (34%). Smoking status: former 111 (55%), never 54 (27%), current 36 (18%), median pack-year 18 (IQR: 0-37). Alcohol use: yes 110 (55%), no 91 (54%). Marijuana use: yes 47 (23%), no 154 (77%). Overall response rate: 36 (18%). Median OS: 12 months (95% CI: 9.4-14.8). Tobacco: former (HR: 0.75, 95% CI: 0.50, 1.11), current (HR: 0.58, 95% CI: 0.33, 1.02). Marijuana: yes (HR: 0.93, 95% CI: 0.58, 1.49). Alcohol: yes (HR: 1.04, 95% CI: 0.72, 1.49).
Conclusion:
In our cohort, smoking status, marijuana use and alcohol consumption did not have a statistically significant impact on OS in patients with R/M HNSCC treated with ICI.
Trial registration: retrospectively registered.
Publisher
Research Square Platform LLC
Reference103 articles.
1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin [Internet]. 2018 Nov;68(6):394–424. Available from: http://doi.wiley.com/10.3322/caac.21492
2. Kawakita D, Matsuo K. Alcohol and head and neck cancer. Cancer Metastasis Rev [Internet]. 2017 Sep 16;36(3):425–34. Available from: http://link.springer.com/10.1007/s10555-017-9690-0
3. Lambert R, Sauvaget C, de Camargo Cancela M, Sankaranarayanan R. Epidemiology of cancer from the oral cavity and oropharynx. Eur J Gastroenterol Hepatol [Internet]. 2011 Aug;23(8):633–41. Available from: http://journals.lww.com/00042737-201108000-00001
4. Head and Neck Cancer: Statistics | Cancer.Net [Internet]. Statistics adapted from the American Cancer Society’s publication, Cancer Facts & Figs, the National Cancer Institute website. 2022, and. 2022 [cited 2022 Sep 5]. Available from: https://www.cancer.net/cancer-types/head-and-neck-cancer/statistics
5. Johnson DE, Burtness B, Leemans CR, Lui VWY, Bauman JE, Grandis JR. Head and neck squamous cell carcinoma. Nat Rev Dis Prim [Internet]. 2020 Nov 26;6(1):92. Available from: https://www.nature.com/articles/s41572-020-00224-3